ROBERT C. KOSKI - 16 Dec 2021 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role
Director
Signature
/s/ Mark A. Catchur, as Attorney-in-Fact for Robert C. Koski
Issuer symbol
OGEN
Transactions as of
16 Dec 2021
Net transactions value
$0
Form type
4
Filing time
17 Dec 2021, 16:09:56 UTC
Next filing
03 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGEN Non-Employee Director Option (Right to Buy) Award $0 +75,000 $0.000000 75,000 16 Dec 2021 Common Stock 75,000 $0.4900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021.